Trademark: 87588325
Word
LYMPHOCOUNT
Status
Dead
Status Code
606
Status Date
Monday, October 28, 2019
Serial Number
87588325
Mark Type
4000
Filing Date
Tuesday, August 29, 2017
Published for Opposition
Tuesday, January 30, 2018
Abandoned Date
Monday, October 28, 2019

Trademark Owner History
INVIVOSCRIBE, INC. - 1st New Owner After Publication
Invivoscribe Technologies, Inc. - Owner At Publication

Classifications
1 Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical research, and laboratory research use
5 Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids
42 DNA analysis services for scientific research purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays
44 DNA screening for medical purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays

Trademark Events
Oct 28, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 28, 2019
Abandonment - No Use Statement Filed
Mar 23, 2019
Notice Of Approval Of Extension Request E-Mailed
Mar 21, 2019
Extension 2 Granted
Mar 21, 2019
Extension 2 Filed
Mar 21, 2019
Teas Extension Received
Sep 29, 2018
Notice Of Approval Of Extension Request E-Mailed
Sep 27, 2018
Extension 1 Granted
Sep 27, 2018
Extension 1 Filed
Sep 27, 2018
Teas Extension Received
Sep 5, 2018
Automatic Update Of Assignment Of Ownership
Mar 28, 2018
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 28, 2018
Teas Change Of Owner Address Received
Mar 27, 2018
Noa E-Mailed - Sou Required From Applicant
Jan 30, 2018
Official Gazette Publication Confirmation E-Mailed
Jan 30, 2018
Published For Opposition
Jan 10, 2018
Notification Of Notice Of Publication E-Mailed
Dec 26, 2017
Assigned To Lie
Dec 5, 2017
Approved For Pub - Principal Register
Dec 5, 2017
Examiner's Amendment Entered
Dec 5, 2017
Notification Of Examiners Amendment E-Mailed
Dec 5, 2017
Examiners Amendment E-Mailed
Dec 5, 2017
Examiners Amendment -Written
Dec 4, 2017
Assigned To Examiner
Sep 6, 2017
New Application Office Supplied Data Entered In Tram
Sep 1, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24